Cargando…

The Effects of Melatonin in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial

BACKGROUND: This study was designed to evaluate the effect of melatonin on nonalcoholic fatty liver disease (NAFLD) in compared to placebo. MATERIALS AND METHODS: A total of 100 patients with histopathological diagnosis NAFLD in two groups of case and control received oral melatonin or placebo thric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pakravan, Hassan, Ahmadian, Mehdi, Fani, Ali, Aghaee, Davood, Brumanad, Sareh, Pakzad, Bahram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414412/ https://www.ncbi.nlm.nih.gov/pubmed/28503495 http://dx.doi.org/10.4103/2277-9175.204593

Ejemplares similares

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Effects of Phlebotomy on Liver Enzymes and Histology of Patients with Nonalcoholic Fatty Liver Disease
por: Khodadoostan, Mahsa, et al.
Publicado: (2017)

Experimental Data on the Role of Melatonin in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Terziev, Dimitar, et al.
Publicado: (2023)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
por: Soleimani, Davood, et al.
Publicado: (2020)

Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial
por: El-Kady, Rasha R., et al.
Publicado: (2022)

Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis
por: Mohammadi, Zahra, et al.
Publicado: (2022)

Effect of garlic powder consumption on body composition in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial
por: Soleimani, Davood, et al.
Publicado: (2016)

Melatonin Levels in Patients with Nonalcoholic Fatty Liver Disease Compared with Healthy Individuals according to Fibrosis Level
por: Sohrabi, Masoudreza, et al.
Publicado: (2021)

Effect of Pioglitazone on Nonalcoholic Fatty Liver Disease in Morbid Obese Patients; a Randomized Controlled Trial
por: Sayadishahraki, Masoud, et al.
Publicado: (2023)

Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial
por: Sakpal, Mallikarjun, et al.
Publicado: (2017)

Soy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
por: Xiong, Pian, et al.
Publicado: (2021)

Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial
por: Yu, Ying-ying, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease
por: Ramanathan, Raghu, et al.
Publicado: (2022)

The Efficacy of Rosa damascena on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial
por: Moravej, S. Ali Al-Hadi, et al.
Publicado: (2021)

Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials
por: An, Jihyun, et al.
Publicado: (2023)

Periodontal Treatment and Usual Care for Nonalcoholic Fatty Liver Disease: A Multicenter, Randomized Controlled Trial
por: Kamata, Yohei, et al.
Publicado: (2022)

Effect of garlic powder supplementation on blood pressure and hs‐C‐reactive protein among nonalcoholic fatty liver disease patients: A randomized, double‐blind, placebo‐controlled trial
por: Soleimani, Davood, et al.
Publicado: (2021)

Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease
por: Soleimani, Davood, et al.
Publicado: (2019)

Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial
por: Kamari, Negin, et al.
Publicado: (2023)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Gut microbiota therapy for nonalcoholic fatty liver disease: Evidence from randomized clinical trials
por: Han, Ting-Rui, et al.
Publicado: (2023)

Effects of coenzyme Q10 supplementation on lipid profiles and liver enzymes of nonalcoholic fatty liver disease (NAFLD) patients: A systematic review and meta‐analysis of randomized controlled trials
por: Ardekani, Ali, et al.
Publicado: (2023)

The Efficacy of Plantago major Seed on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial
por: Jazayeri, Seyedeh Ferdows, et al.
Publicado: (2021)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

The Effect of Follow up (Telenursing) on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
por: Fard, Sorur Javanmardi, et al.
Publicado: (2016)

Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
por: Harrison, Stephen A., et al.
Publicado: (2023)

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Sesame Oil Ameliorates Alanine Aminotransferase, Aspartate Aminotransferase, and Fatty Liver Grade in Women with Nonalcoholic Fatty Liver Disease Undergoing Low-Calorie Diet: A Randomized Double-Blind Controlled Trial
por: Atefi, Masoumeh, et al.
Publicado: (2022)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
por: Ebrahimi, Menooa, et al.
Publicado: (2023)

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
por: Younossi, Zobair M., et al.
Publicado: (2017)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Effect of silymarin on liver size and nonalcoholic fatty liver disease in morbidly obese patients: A randomized double-blind clinical trial
por: Atarodi, Hamed, et al.
Publicado: (2022)

An Accessible and Pragmatic Experimental Model of Nonalcoholic Fatty Liver Disease
por: Emamat, Hadi, et al.
Publicado: (2016)

Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease: The TREATY-FLD Randomized Clinical Trial
por: Wei, Xueyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2cjd8rfvlbro3j5i8c9mp3etcs